Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 Dec 6;293(6560):1456–1457. doi: 10.1136/bmj.293.6560.1456

Primary pulmonary hypertension.

T Higenbottam
PMCID: PMC1342234  PMID: 3099910

Full text

PDF
1456

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROWN J. W., HEATH D., WHITAKER W. Idiopathic pulmonary hypertension. Br Heart J. 1957 Jan;19(1):83–92. doi: 10.1136/hrt.19.1.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bjornsson J., Edwards W. D. Primary pulmonary hypertension: a histopathologic study of 80 cases. Mayo Clin Proc. 1985 Jan;60(1):16–25. doi: 10.1016/s0025-6196(12)65277-x. [DOI] [PubMed] [Google Scholar]
  3. Bourdillon P. D., Oakley C. M. Regression of primary pulmonary hypertension. Br Heart J. 1976 Mar;38(3):264–270. doi: 10.1136/hrt.38.3.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carreras L. O., Defreyn G., Machin S. J., Vermylen J., Deman R., Spitz B., Van Assche A. Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet. 1981 Jan 31;1(8214):244–246. doi: 10.1016/s0140-6736(81)92087-0. [DOI] [PubMed] [Google Scholar]
  5. Carreras L. O., Vermylen J. G. "Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation. Thromb Haemost. 1982 Aug 24;48(1):38–40. [PubMed] [Google Scholar]
  6. Crevey B. J., Dantzker D. R., Bower J. S., Popat K. D., Walker S. D. Hemodynamic and gas exchange effects of intravenous diltiazem in patients with pulmonary hypertension. Am J Cardiol. 1982 Feb 18;49(3):578–583. doi: 10.1016/s0002-9149(82)80015-5. [DOI] [PubMed] [Google Scholar]
  7. D'Alonzo G. E., Gianotti L., Dantzker D. R. Noninvasive assessment of hemodynamic improvement during chronic vasodilator therapy in obliterative pulmonary hypertension. Am Rev Respir Dis. 1986 Mar;133(3):380–384. doi: 10.1164/arrd.1986.133.3.380. [DOI] [PubMed] [Google Scholar]
  8. Daily P. O., Johnston G. G., Simmons C. J., Moser K. M. Surgical management of chronic pulmonary embolism: surgical treatment and late results. J Thorac Cardiovasc Surg. 1980 Apr;79(4):523–531. [PubMed] [Google Scholar]
  9. Douglas J. G., Munro J. F., Kitchin A. H., Muir A. L., Proudfoot A. T. Pulmonary hypertension and fenfluramine. Br Med J (Clin Res Ed) 1981 Oct 3;283(6296):881–883. doi: 10.1136/bmj.283.6296.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fuster V., Steele P. M., Edwards W. D., Gersh B. J., McGoon M. D., Frye R. L. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation. 1984 Oct;70(4):580–587. doi: 10.1161/01.cir.70.4.580. [DOI] [PubMed] [Google Scholar]
  11. Goodman D. J., Harrison D. C., Popp R. L. Echocardiographic features of primary pulmonary hypertension. Am J Cardiol. 1974 Mar;33(3):438–443. doi: 10.1016/0002-9149(74)90329-4. [DOI] [PubMed] [Google Scholar]
  12. Gurtner H. P., Gertsch M., Salzmann C., Scherrer M., Stucki P., Wyss F. Häufen sich die primär vasculären Formen des chronischen Cor pulmonale? Schweiz Med Wochenschr. 1968 Oct 12;98(41):1579–contd. [PubMed] [Google Scholar]
  13. Hatle L., Angelsen B. A., Tromsdal A. Non-invasive estimation of pulmonary artery systolic pressure with Doppler ultrasound. Br Heart J. 1981 Feb;45(2):157–165. doi: 10.1136/hrt.45.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Higenbottam T., Wheeldon D., Wells F., Wallwork J. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet. 1984 May 12;1(8385):1046–1047. doi: 10.1016/s0140-6736(84)91452-1. [DOI] [PubMed] [Google Scholar]
  15. Ikram H., Maslowski A. H., Nicholls M. G., Espiner E. A., Hull F. T. Haemodynamic and hormonal effects of captopril in primary pulmonary hypertension. Br Heart J. 1982 Dec;48(6):541–545. doi: 10.1136/hrt.48.6.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Loogen F., Both A. Primäre pulmonale hypertonie. Z Kardiol. 1976 Jan;65(1):1–14. [PubMed] [Google Scholar]
  17. Moncada S., Gryglewski R., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976 Oct 21;263(5579):663–665. doi: 10.1038/263663a0. [DOI] [PubMed] [Google Scholar]
  18. Packer M., Greenberg B., Massie B., Dash H. Deleterious effects of hydralazine in patients with pulmonary hypertension. N Engl J Med. 1982 Jun 3;306(22):1326–1331. doi: 10.1056/NEJM198206033062203. [DOI] [PubMed] [Google Scholar]
  19. Reid L. M. Structure and function in pulmonary hypertension. New perceptions. Chest. 1986 Feb;89(2):279–288. doi: 10.1378/chest.89.2.279. [DOI] [PubMed] [Google Scholar]
  20. Rich S., D'Alonzo G. E., Dantzker D. R., Levy P. S. Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertension. Am J Cardiol. 1985 Jan 1;55(1):159–163. doi: 10.1016/0002-9149(85)90319-4. [DOI] [PubMed] [Google Scholar]
  21. Rozkovec A., Montanes P., Oakley C. M. Factors that influence the outcome of primary pulmonary hypertension. Br Heart J. 1986 May;55(5):449–458. doi: 10.1136/hrt.55.5.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rubin L. J., Groves B. M., Reeves J. T., Frosolono M., Handel F., Cato A. E. Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension. Circulation. 1982 Aug;66(2):334–338. doi: 10.1161/01.cir.66.2.334. [DOI] [PubMed] [Google Scholar]
  23. Rubin L. J., Peter R. H. Oral hydralazine therapy for primary pulmonary hypertension. N Engl J Med. 1980 Jan 10;302(2):69–73. doi: 10.1056/NEJM198001103020201. [DOI] [PubMed] [Google Scholar]
  24. Rubino J. M., Schroeder J. S. Diazoxide in treatment of primary pulmonary hypertension. Br Heart J. 1979 Sep;42(3):362–363. doi: 10.1136/hrt.42.3.362. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES